Detalhe da pesquisa
1.
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
Epidemiol Infect
; 149: e32, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33461632
2.
A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis.
Pharmacogenet Genomics
; 27(2): 51-56, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27922550
3.
Validation of the Besta Neurological Institute rating scale for myasthenia gravis.
Muscle Nerve
; 53(1): 32-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26372817
4.
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants.
Neurology
; 101(9): e892-e903, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414564
5.
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
Front Immunol
; 13: 1070379, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591311
6.
Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy.
J Neurol
; 268(7): 2331-2338, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33026520
7.
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability.
Mult Scler J Exp Transl Clin
; 3(2): 2055217317701317, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607756
8.
A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients.
Immunobiology
; 221(11): 1227-36, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27387891
9.
Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Immunobiology
; 221(4): 516-27, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26723518
10.
A new thiopurine s-methyltransferase haplotype associated with intolerance to azathioprine.
J Clin Pharmacol
; 53(1): 67-74, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23400745
11.
Current and emerging therapies for the treatment of myasthenia gravis.
Neuropsychiatr Dis Treat
; 7: 151-60, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21552317